Renal interstitial permeability changes induced by microbubble-enhanced diagnostic ultrasound

References

• Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69:213–17
   PubMed Web of Science ®Google Scholar
• Remuzzi G, Cattaneo D, Perico N. The aggravating mechanisms of aldosteroneon kidney fibrosis. J Am Soc Nephrol 2008;19:1459–62
   PubMed Web of Science ®Google Scholar
• Yu L, Noble NA, Border WA. Therapeutic strategies to halt renal fibrosis. Curr Opin Pharmacol 2002;2:177–81
   PubMed Web of Science ®Google Scholar
• Ripley E. Complementary effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in slowing the progression of chronic kidney disease. Am Heart J 2009;157:S7–16
   PubMed Web of Science ®Google Scholar
• Fretz MM, Dolman ME, Lacombe M, et al. Intervention in growth factor activated signaling pathways by renally targeted kinase inhibitors. J Control Release 2008;132:200–7
   PubMed Web of Science ®Google Scholar
• Guney I, Selcuk NY, Altintepe L, et al. Antifibrotic effects of aldosterone receptor blocker (spironolactone) in patients with chronic kidney disease. Ren Fail 2009;3:1779–84
   Google Scholar
• Nishida M, Okumura Y, Sato H, Hamaoka K. Delayed inhibition of p38 mitogen activated protein kinase ameliorates renal fibrosis in obstructive nephropathy. Nephrol Dial Transplant 2008;23:2520–4
   PubMed Web of Science ®Google Scholar
• Robert C, Soria JC, Spatz A, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005;6:491–500
   PubMed Web of Science ®Google Scholar
• Chu TF, Rupnick MA, Kerkela R, et al. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 2007;370:2011–19
   PubMed Web of Science ®Google Scholar
• Kerkelä R, Grazette L, Yacobi R, et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med 2006;12:908–16
   PubMed Web of Science ®Google Scholar
• Dolman ME, Harmsen S, Storm G, et al. Drug targeting to the kidney: advances in the active targeting of therapeutics to proximal tubular cells. Advanced Drug Delivery Reviews 2010;62:1344–57
   PubMed Web of Science ®Google Scholar
• Satchell SC, Braet F. Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier. Am J Physiol Ren Physiol 2009;296:947–56
   PubMed Web of Science ®Google Scholar
• Atherton JC. Renal blood flow, glomerular filtration and plasma clearance. Anaesthesia Intensive Care Med 2009;10:271–5
   Google Scholar
• Schipper ML, Iyer G, Koh AL, et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 2009;5:126--34
   Google Scholar
• Takakura Y, Mahato RI, Nishikawa M, Hashida M. Control of pharmacokinetic profiles of drug-macromolecule conjugates. Adv Drug Deliv Rev 1996;19:377--99
   Google Scholar
• Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: from therapeutics to diagnostics. J Pharm Sci 2005;94:2135–46
   PubMed Web of Science ®Google Scholar
• Hagenbuch B. Drug uptake systems in liver and kidney: a historic perspective. Clin Pharmacol Ther 2010;87:39–47
   PubMed Web of Science ®Google Scholar
• Tinkov S, Bekeredjian R, Winter G, Coester C. Microbubbles as ultrasound triggered drug carriers. J Pharm Sci 2009;98:1935–61
   PubMed Web of Science ®Google Scholar
• Mayer CR, Geis NA, Katus HA, Bekeredjian R. Ultrasound targeted microbubble destruction for drug and gene delivery. Expert Opin Drug Deliv 2008;5:1121–38
   PubMed Web of Science ®Google Scholar
• Hernot S, Klibanov AL. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008;30: 60, 1153–66
   Google Scholar
• Miller DL, Dou C, Wiggins RC. In vivo gas body efficacy for glomerular capillary hemorrhage induced by diagnostic ultrasound in rats. IEEE Trans Biomed Eng 2010;57:169–74
   Google Scholar
• Williams AR, Wiggins RC, Wharram BL, et al. Nephron injury induced by diagnostic ultrasound imaging at high mechanical index with gas body contrast agent. Ultrasound Med Biol 2007;33:1336–44
   PubMed Web of Science ®Google Scholar
• Fischer K, McDannold NJ, Zhang Y, et al. Renal ultrafiltration changes induced by focused US. Radiology 2009;253:697–705
   PubMed Web of Science ®Google Scholar
• Liu P, Wang X, Zhou S, et al. Effects of a novel ultrasound contrast agent with long persistence on right ventricular pressure: comparison with SonoVue. Ultrasonics 2011;51:210–14
   PubMed Web of Science ®Google Scholar
• Udaka K, Takeuchi Y, Movat HZ. Simple method for quantitation of enhanced vascular permeability. Proc Soc Exp Biol Med 1970;133:1384–7
   PubMed Web of Science ®Google Scholar
• Miller DL, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci 2000;97:10179–84
   PubMed Web of Science ®Google Scholar
• Zheng Z, Schmidt-Ott KM, Chua S, et al. A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Nat Acad Sci USA 2005;102:2502–7
   PubMed Web of Science ®Google Scholar
• Johnson K, Cianciolo R, Gessner RC, Dayton PA. A pilot study to assess markers of renal damage in the rodent kidney after exposure to 7 MHz ultrasound pulse sequences designed to cause microbubble translation and disruption. Ultrasound in Med Biol 2012;38:168–72
   PubMed Web of Science ®Google Scholar
• O’Brien Jr WD. Ultrasound-biophysics mechanisms. Prog Biophys Mol Biol 2007;93:212–55
   PubMed Web of Science ®Google Scholar
• Deelman LE, Declèves AE, Rychak JJ, Sharma K. Targeted renal therapies through microbubbles and ultrasound. Adv Drug Deliv Rev 2010;62:1369–77
   PubMed Web of Science ®Google Scholar
• Miller DL, Averkiou MA, Brayman AA, et al. Bioeffects considerations for diagnostic ultrasound contrast agents. J Ultrasound Med 2008;27:611–32
   PubMed Web of Science ®Google Scholar
• Song J, Chappell JC, Qi M, et al. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol 2002;39:726–31
   PubMed Web of Science ®Google Scholar
• Skyba DM, Price RJ, Linka AZ, et al. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998;98:290–3
   PubMed Web of Science ®Google Scholar
• Wible Jr JH, Galen KP, Wojdyla JK, et al. Microbubbles induce renal hemorrhage when exposed to diagnostic ultrasound in anesthetized rats. Ultrasound Med Biol 2002;28:1535–46
   PubMed Web of Science ®Google Scholar
• Caskey CF, Qin S, Dayton PA, Ferrara KW. Microbubble tunneling in gel phantoms. J Acoust Soc Am 2009;125:EL183–9
   PubMed Web of Science ®Google Scholar
• Miller DL, Dou C, Wiggins RC. Frequency dependence of kidney injury induced by contrast-aided diagnostic ultrasound in rats. Ultrasound Med Biol 2008;34:1678–87
   PubMed Web of Science ®Google Scholar
• Miller DL, Dou C, Wiggins RC, et al. An in vivo rat model simulating imaging of human kidney by diagnostic ultrasound with gas-body contrast agent. Ultrasound Med Biol 2007;33:129–35
   PubMed Web of Science ®Google Scholar